Parkinson’s Disease

A slowly progressive neurologic disease that is characterized by a fixed inexpressive face, tremor at rest, slowing of voluntary movements, gait with short accelerating steps, peculiar posture and muscle weakness (caused by degeneration of an area of the brain called the basal ganglia), and low production of the neurotransmitter dopamine. Most patients are over 50, but at least 10 percent are under 40. Treatment involves use of medication, such as levodopa (brand name: Larodopa) and carbidopa (brand name: Sinemet).

  • Pneumonia
  • Multiple Systems Atrophy
  • Progressive Supranuclear Palsy
  • Normal Pressure Hydrocephalus
  • Huntington’s Disease

Related Conference of Parkinson’s Disease

August 12-13, 2019

4th International Conference on Clinical and Counseling Psychology

| Radisson Hotel Narita | Tokyo, Japan
September 05-06, 2019

European Psychiatrists Meeting

Budapest, Hungary
September 16-17, 2019

36th International Conference on Psychiatry & Psychosomatic Medicine

| Holiday Inn Rome – Aurelia, Rome, Italy
October 07-08, 2019

11th Worldwide Forum on Mental Health & Psychiatry

Rome, Italy
October 21-22, 2019

2nd Annual Congress on Psychiatric & Mental Health Nursing

Amsterdam, Netherlands

CME and CPD ACCREDITED CONFERENCE
Conference Date: October 21 & 22, 2019

International Summit on Mental Disorders and Illness

Venue: Geneva, Switzerland
November 11-12, 2019

2nd Euro Depression Congress

Amsterdam, Netherlands
November 14-15, 2019

7th World Congress on Depression and Anxiety

Brisbane, Australia
November 21-22, 2019

3rd International Conference on Clinical Psychology

Zagreb, Croatia

Parkinson’s Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in